Home Weight Loss Tips Most Americans don’t think new weight loss drugs will help U.S. obesity rate – The Hill

Most Americans don’t think new weight loss drugs will help U.S. obesity rate – The Hill

0
Most Americans don’t think new weight loss drugs will help U.S. obesity rate – The Hill
  • A latest Pew Analysis Middle examine discovered that the majority Individuals don’t suppose that new injectable weight reduction medicine like Ozempic will do a lot to assist weight problems within the U.S. 

  • About 42 % of adults within the U.S. are overweight, in keeping with the CDC. 

  • 65 % of Individuals don’t suppose willpower alone is sufficient to reduce weight and maintain it off.  

Nearly 70 % of Individuals don’t suppose that new weight reduction medicine like Ozempic and Wegovy could have a lot of an affect on the nation’s weight problems fee, in keeping with a latest Pew Analysis Middle survey.  

The U.S. weight problems fee has climbed over the previous 20 years, with about 42 % of American adults now categorized as overweight, in keeping with the Facilities for Illness Management and Prevention.

Ozempic and Wegovy are a part of a category of medication referred to as GLP-1 agonists that handle blood sugar ranges and suppress urge for food. The Meals and Drug Administration (FDA) has accepted Ozempic for managing Sort 2 diabetes.  

Wegovy is a weekly injectable drug accepted by the FDA for long-term weight administration. Different comparable medicine are Mounjaro and Zepbound.  

Whereas some have lauded the medicine as a breakthrough in weight problems remedy, most Individuals are skeptical as to how a lot they are going to assist Individuals with severe weight points.

Within the survey, carried out from Feb. 7 to Feb. 11, researchers discovered that 35 % of Individuals suppose the medicine will do one thing to scale back weight problems within the nation, whereas 33 % imagine they won’t do a lot or nothing in any respect.

Simply 16 % of individuals suppose the injections will do an awesome deal or loads to scale back weight problems, and 15 % aren’t certain, in keeping with the survey.

Ozempic and Wegovy’s growth in recognition has began a bigger dialogue within the U.S. about how genetics play a task in how efficiently somebody can reduce weight as a lot as conduct.

The survey additionally discovered that 65 % of Individuals don’t suppose willpower alone is sufficient to lose and maintain weight off.

The margin of sampling error for the survey is plus or minus 1.5 share factors.


Copyright 2024 Nexstar Media Inc. All rights reserved. This materials might not be printed, broadcast, rewritten, or redistributed.

LEAVE A REPLY

Please enter your comment!
Please enter your name here